Calendar Notable Labs, Ltd.

Equities

End-of-day quote Nasdaq Other stock markets 23:00:00 25/04/2024 BST			5-day change	1st Jan Change
0.965 ^USD	+0.51%		-1.03%	-48.94%

04-15	Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating	MT
04-15	Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating	MT

35192c867.KBroI0oodf_Lpm2264yyEgqsjD70S6EaSne9heQT0A8.cFTRFQdlEr2pygbB2Lz-WGvm2mywP5JMcwHa4L1xkmdeS6ZVBWYZla_uOA~ea4354c542bdf5f5b5fe7e5798fab7a2

No events available

12/04/2024 13:00	Q4 2023 Earnings Release
09/04/2024 17:00	American Association for Cancer Research Meeting - Abstract No:5178
08/04/2024 17:00	American Association for Cancer Research Meeting - Abstract No:2548
15/05/2023 21:01	Q1 2023 Earnings Release
14/03/2023 12:00	Q4 2022 Earnings Release
23/02/2023 13:30	Vascular Biogenics Ltd. and Notable Labs Merger Call
14/11/2022 21:05	Q3 2022 Earnings Release
15/08/2022 21:05	Interim 2022 Earnings Release
08/06/2022 20:00	Jefferies Healthcare Conference
02/06/2022	American Society of Clinical Oncology Meeting
22/05/2022	H.C. Wainwright Global Life Sciences Investment Conference
17/05/2022 13:30	Q1 2022 Earnings Call
17/05/2022 12:00	Q1 2022 Earnings Release
12/05/2022 07:30	Biomed Israel Conference
11/05/2022 18:00	LifeSci Partners Immunology & Inflammation Symposium
08/05/2022 22:30	IMMUNOLGY Meeting
11/04/2022 17:00	Investor Meeting - KOL
23/03/2022 12:30	FY 2021 Earnings Call
23/03/2022 11:00	FY 2021 Earnings Release
16/03/2022 12:40	Oppenheimer Healthcare Conference

Fiscal Period	December	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00	0,31 0,00 -	0,00
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	0,00	-14,7 -14,5 -1.03%	-16,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-11,3 -14,5 22.33%	-16,8
Net income Million USD	Released Forecast Spread	-14,4	-11,3 -14,5 22.33%	-14,5
EPS USD	Released Forecast Spread	-1,38	-3,41 -1,62 -110.49%	-1,50
Announcement Date		01/09/23	11/04/24	-

Fiscal Period	December	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales Million USD	Released Forecast Spread	0,12 0,00 -	0,19 0,00 -	0,00	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-1,75 -3,71 52.78%	-4,40 -3,88 -13.48%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	2,89 -3,71 178.06%	-4,45 -3,87 -14.9%
Net income Million USD	Released Forecast Spread	2,89 -3,71 178.06%	-4,45 -3,87 -14.9%
EPS USD	Released Forecast Spread	0,19 -0,41 146.34%	-2,97 -0,43 -590.7%	-0,39	-0,43	-0,52	-0,56	-0,60
Announcement Date		29/11/23	11/04/24	-	-	-	-	-

29/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
29/04/2024	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
30/04/2024 21:05	EXELIXIS, INC.: Q1 2024 Earnings Release
30/04/2024	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
30/04/2024	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 12:00	NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release

Today	HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
25/04/2024	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
25/04/2024	REMEGEN CO., LTD.: Q1 2024 Earnings Release
25/04/2024 21:05	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 11:30	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release